TrialJournal of clinical immunology2016

Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.

Richard L Wasserman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.